Cargando…
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
There are no approved diagnostic biomarkers for at-risk non-alcoholic steatohepatitis (NASH), defined by the presence of NASH, high histological activity and fibrosis stage ≥2, which is associated with higher incidence of liver-related events and mortality. FNIH-NIMBLE is a multi-stakeholder project...
Autores principales: | Sanyal, Arun J., Shankar, Sudha S., Yates, Katherine P., Bolognese, James, Daly, Erika, Dehn, Clayton A., Neuschwander-Tetri, Brent, Kowdley, Kris, Vuppalanchi, Raj, Behling, Cynthia, Tonascia, James, Samir, Anthony, Sirlin, Claude, Sherlock, Sarah P., Fowler, Kathryn, Heymann, Helen, Kamphaus, Tania N., Loomba, Rohit, Calle, Roberto A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579051/ https://www.ncbi.nlm.nih.gov/pubmed/37679433 http://dx.doi.org/10.1038/s41591-023-02539-6 |
Ejemplares similares
-
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis
por: Sanyal, Arun, et al.
Publicado: (2023) -
Validation of the accuracy of the FAST(™) score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms
por: Woreta, Tinsay A., et al.
Publicado: (2022) -
The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance
por: Gill, Ryan M., et al.
Publicado: (2023) -
The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020) -
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
por: Kleiner, David E., et al.
Publicado: (2019)